コーパス検索結果 (left1)
通し番号をクリックするとPubMedの該当ページを表示します
1 SPARC (Secreted Protein Acidic and Rich in Cysteine), is
2 SPARC (secreted protein acidic rich in cysteine) is an a
3 SPARC and myocilin mRNA expression were dramatically inc
4 SPARC and myocilin protein expression paralleled changes
5 SPARC binding does not distort the canonical triple heli
6 SPARC deficiency resulted in endoglin-mediated blockade
7 SPARC enhanced signaling by integrin-linked kinase (ILK)
8 SPARC expression in human adipose tissue correlated with
9 SPARC expression is increased in ACC samples by 1.56 +/-
10 SPARC expression was correlated with leptin independent
11 SPARC expression was measured by immunoblot.
12 SPARC in the stroma, but not in the tumor, was correlate
13 SPARC interacted directly with endoglin and reduced endo
14 SPARC is a matricellular protein often associated with f
15 SPARC is a matricellular protein that is highly expresse
16 SPARC is a matricellular protein that is involved in bot
17 SPARC is a regulatory node for IOP.
18 SPARC is known to be upregulated in the tumor microenvir
19 SPARC is not synaptogenic, but specifically antagonizes
20 SPARC is secreted at high levels by pancreatic stellate
21 SPARC is thus a novel regulator of microglial proliferat
22 SPARC levels were positively correlated with GSIS in isl
23 SPARC may be a downstream regulatory node of TGF-beta2-m
24 SPARC null/CX3CR1-GFP reporter mice reveal that SPARC re
25 SPARC overexpression decreased STAT3 phosphorylation; co
26 SPARC overexpression increased the IOP of perfused human
27 SPARC overexpression increases IOP in perfused cadaveric
28 SPARC production peaks when innervation of the rat super
29 SPARC recognizes the GVMGFO motifs of the middle and tra
30 SPARC reduced carcinogen-induced inflammation and accumu
31 SPARC retarded the morphological changes exhibited by pr
32 SPARC was expressed at measurable levels in human islets
33 SPARC was suppressed 31 +/- 13% (n = 5, P < 0.0001) by s
34 SPARC was upregulated by TGF-beta2 in the human TM cells
35 SPARC-like 1 (SC1) is a member of the SPARC family of ma
36 SPARC-null animals develop cataracts associated with a d
37 SPARC-null mice demonstrate a lower IOP resulting from i
38 SPARC-null mice demonstrated a more uniform outflow patt
39 SPARC-null mice had a 23% decrease in IOP.
40 SPARC-null mice have a 15% to 20% decrease in intraocula
41 SPARC-null mice have lower intraocular pressure (IOP).
42 SPARC-null mice have lower IOPs than do their WT counter
43 SPARC-Related Modular Calcium Binding Protein-2 (Smoc-2)
44 SPARC/Osteonectin (SP/ON) is implicated in the regulatio
46 he hematopoietic system is normal, HSCs in a SPARC-deficient niche show an accelerated return to quie
49 in 6 (IL-6) and supplemented IL-6-abrogated, SPARC-mediated suppression of Notch signaling and expres
54 ecombinant leptin, insulin, and glucose, and SPARC mRNA and protein expression determined by Western
56 d two astrocyte-secreted proteins, hevin and SPARC, as regulators of excitatory synaptogenesis in vit
57 h regulation of relative levels of hevin and SPARC, astrocytes might control the formation, maturatio
58 tive models, ABSOLV, COSMOtherm, KOWWIN, and SPARC to calculate storage lipid-water partition coeffic
59 ese results identify hevin as a positive and SPARC as a negative regulator of synapse formation and s
62 ediating detachment, cultured SPARC(+/+) and SPARC(-/-) podocytes were subjected to mechanical strain
67 nce of SPARC, age-matched wild-type (WT) and SPARC-null mice underwent either transverse aortic const
69 he data supporting this relationship between SPARC and nab-paclitaxel remain largely correlative at t
77 pression in IPF fibroblasts was regulated by SPARC-mediated activation of Akt, leading to inhibition
85 e had fewer excitatory synapses; conversely, SPARC-null mice had increased synaptic connections in th
86 stroke in the forelimb sensorimotor cortex, SPARC nulls demonstrate enhanced microgliosis in and aro
87 n primary prostate tumorigenesis, we crossed SPARC-null (SP(-/-)) with TRAMP (Transgenic Adenocarcino
88 for SPARC in mediating detachment, cultured SPARC(+/+) and SPARC(-/-) podocytes were subjected to me
89 ecreted protein acidic and rich in cysteine (SPARC) and collagen-I and induction of complement activa
91 creted protein, acidic and rich in cysteine (SPARC) family matricellular protein, during invasive pha
92 ecreted protein acidic and rich in cysteine (SPARC) has been implicated in multiple aspects of human
93 ecreted protein acidic and rich in cysteine (SPARC) is a matricellular protein known to regulate extr
94 ecreted protein acidic and rich in cysteine (SPARC) is a matricellular protein that is important for
95 Secreted protein acidic rich in cysteine (SPARC) is a matricellular protein that modulates the act
96 ecreted protein acidic and rich in cysteine (SPARC) is important for the normal growth and maintenanc
97 ecreted protein acidic and rich in cysteine (SPARC) is up-regulated and expressed intracellularly in
98 ecreted protein acidic and rich in cysteine (SPARC) participates in the regulation of morphogenesis a
99 ecreted protein acidic and rich in cysteine (SPARC) plays a key role in post-synthetic procollagen pr
100 creted protein, acidic and rich in cysteine (SPARC) were among those substrates we biochemically conf
101 ecreted protein acidic and rich in cysteine (SPARC), a matricellular protein with counteradhesive pro
102 ecreted protein acidic and rich in cysteine (SPARC), a molecule produced by glial cells, is involved
103 ecreted Protein Acidic and Rich in Cysteine (SPARC), a protein involved in mammalian cardiac function
104 ecreted protein acidic and rich in cysteine (SPARC), although the data supporting this relationship b
106 creted Protein, Acidic and Rich in Cysteine (SPARC), originally discovered in bone as osteonectin, is
107 ecreted protein acidic and rich in cysteine (SPARC), which significantly stimulated the expression of
108 ecreted protein acidic and rich in cysteine (SPARC)-deficient mice exhibited decreased pericyte-assoc
109 reted Protein, Acidic, and Rich in Cysteine (SPARC)-null mice have a lower intraocular pressure.
113 dels revealed that tumor- and stroma-derived SPARC reduced tumor growth and metastasis through inhibi
115 our approach improves contrast because each SPARC-targeting molecule delivers a large number of nano
116 ibroblasts that is characterized by elevated SPARC, giving rise to activated beta-catenin, which regu
122 es for alkyl PAHs deviated increasingly from SPARC log K(OW) values with increasing degree of alkylat
125 oteoglycans - including fibulin, hemicentin, SPARC, agrin, and type XVIII collagen - are present in B
126 The matricellular SPARC family member hevin (SPARC-like 1/SPARCL-1/SC1/Mast9) contributes to neural d
130 ystal structure at 3.2 A resolution of human SPARC bound to a triple-helical 33-residue peptide harbo
131 nvasion of breast carcinoma cells identified SPARC, or secreted protein acidic and rich in cysteine.
132 4 integrin expression and signaling impacted SPARC expression and that SPARC facilitates beta4-mediat
137 ations form an intramolecular salt bridge in SPARC and are essential for the binding of SPARC to coll
140 e alpha-, beta-, and gamma-actin isoforms in SPARC knockout myoblasts reveals a changed expression pa
141 myocardial diastolic stiffness was lower in SPARC-null TAC mice (0.075+/-0.005) than in WT TAC mice
142 servations show that homozygous mutations in SPARC can give rise to severe bone fragility in humans.
144 Moreover, the preserved podocyte number in SPARC(-/-) mice correlates with reduced urinary levels o
145 ments suggest that aqueous turnover rates in SPARC-null mice are equal to if not greater than rates i
146 s ameliorated, and proteinuria is reduced in SPARC(-/-) mice as compared with SPARC(+/+) littermates.
147 ion of the SP1/NF-kappaB complex resulted in SPARC downregulation and leukemia growth inhibition.
148 IV, we identified two homozygous variants in SPARC (GenBank: NM_003118.3; c.497G>A [p.Arg166His] in i
149 containing human SPARC was used to increase SPARC expression in human TM endothelial cells and perfu
151 d that leptin and insulin potently increased SPARC production dose dependently in visceral adipose ti
152 ture amoeboid myeloid precursors only induce SPARC expression after they cease proliferation and migr
155 kers, including laminin, J6(Hsp 47), and J31(SPARC, osteonectin) were expressed at lower levels in RA
158 oss induced by very-low-calorie diet lowered SPARC expression by 33% and increased by 30% in adipose
163 FBI), interaction with the microenvironment (SPARC), retinoic acid signaling (RBP1), and the response
164 capable of processing and thereby modulating SPARC, a protein implicated in bone metastasis and infla
165 The selected mRNAs (IL-6, IL-8, myocilin, SPARC [secreted protein, acidic and rich in cysteine], m
169 olic function are affected by the absence of SPARC, age-matched wild-type (WT) and SPARC-null mice un
179 s segmental, and that transgenic deletion of SPARC causes a more uniform pattern that correlates with
180 indicated that the copper binding domain of SPARC is required for SPARC-mediated response to stress.
182 herefore aimed to characterise the effect of SPARC on beta-cell function and features of diabetes.
185 gether, our data indicate that evaluation of SPARC expression has prognosticative value and SPARC is
187 -induced detachment, stable re-expression of SPARC restored detachment rates to levels comparable wit
188 ned therapy attenuates in vivo expression of SPARC, increases microvessel density, and enhances drug
189 F silencing also decreased the expression of SPARC, phospho-FAK and FAK and overexpression of SPARC a
190 -regulated DNMTs and increased expression of SPARC, which led to tumor growth suppression in bone in
191 hs post-instillation to assess the impact of SPARC on multiple stages in the development of fibrosis.
192 tion, an effect which appears independent of SPARC's modulation of obesity-induced insulin resistance
193 Our results highlight a complex influence of SPARC over the stromal and hematopoietic BM response in
195 umor tissues, the frequency and intensity of SPARC expression were inversely correlated with disease-
198 injury study to investigate whether lack of SPARC would compromise the ability to repair muscle.
201 tutively expressed increased basal levels of SPARC, plasminogen activator inhibitor-1 (PAI-1), and ac
202 wild-type littermates, we found that loss of SPARC accelerated the development of urothelial preneopl
204 in Drosophila and suggest that modulation of SPARC gene expression may ameliorate cardiac dysfunction
205 C, phospho-FAK and FAK and overexpression of SPARC abrogated the inhibitory effect of CTGF silencing
206 w that adenoviral-mediated overexpression of SPARC cDNA (Ad-DsRed-SP) elevated the expression of the
208 h signaling is suppressed in the presence of SPARC, as well as the Notch effector basic helix-loop-he
209 action increased secretion and processing of SPARC, as did co-cultures of bone marrow stromal cells w
213 ray data, confirmed the expected reversal of SPARC gene suppression after treating HT-29 cells with 5
215 is protective effect is not due to a role of SPARC in HSCs, but rather is due to its function in the
220 of this study was to investigate the role of SPARC in the regulation of beta cell growth and survival
224 ving further support to the potential use of SPARC as a therapeutic candidate for medulloblastoma tre
225 g and/or activity of ILK, integrin beta1, or SPARC resulted in increased apoptosis of stressed LEC.
226 ar fragment approaches (EPISuite's KOCWIN or SPARC), poly parameter linear free energy relationship (
229 rotein, acidic, cysteine-rich (osteonectin) (SPARC) gene, which encodes a matricellular protein that
230 rophin, along with required binding partners SPARC/SPARCL1 and HSP90B, as key mediators of this chemo
232 es the stromal-derived matricellular protein SPARC as a novel regulator of islet survival and beta ce
234 e implication of the multifunctional protein SPARC (Secreted protein acidic and rich in cysteine)/ost
239 is study demonstrate that beta4 can regulate SPARC expression and that SPARC is an effector of beta4-
240 c microglia rapidly downregulate and release SPARC at the lesion, concomitant with reactive, hypertro
242 of secreted protein, acidic, cysteine rich (SPARC), myocilin, angiopoietin-like factor (ANGPTL)-7, a
243 Secreted protein, acidic, cysteine-rich (SPARC) is a glycoprotein that binds to collagen type I a
244 , FBLN1, FHL1, FN, NKTR, OGN, PARVA, S100A6, SPARC, STC1 and ZEB1 proteins showed specific and varied
246 ings demonstrate that both tumor and stromal SPARC are limiting for primary prostate tumorigenesis an
247 istinct contributions of tumoral and stromal SPARC to tumorigenesis and progression are unclear.
248 To determine the contribution of stromal SPARC, we evaluated subcutaneous tumor growth of TRAMP c
249 tor: nongerminal center B cell-like subtype, SPARC (secreted protein, acidic, and rich in cysteine) <
251 engineered to display a peptide that targets SPARC glycoprotein, which is overexpressed in various ca
254 -) mice and BM chimeras, we demonstrate that SPARC contributes to the development of significant stro
261 Therefore, we tested the hypothesis that SPARC in human adipose tissue is influenced by glucose m
265 We show using immunohistochemistry that SPARC is expressed by stromal cells within islets and ca
272 RC null/CX3CR1-GFP reporter mice reveal that SPARC regulates the distribution and branching of mature
276 Taken together, our results suggest that SPARC induces expression of neuronal markers in medullob
277 in bone in vivo These findings suggest that SPARC plays a key role in maintaining the dormancy of pr
279 in myopathies, which together suggests that SPARC might serve a specific role within muscle cells.
281 n levels and patterns are not altered in the SPARC null mouse, suggesting that SC1 does not compensat
282 collagen that was soluble was greater in the SPARC-null TAC mice (14+/-2%) than in WT TAC mice (1+/-2
283 collagen that was insoluble was less in the SPARC-null TAC mice (86+/-2%) than in WT TAC mice (99+/-
284 portance of addressing the complexity of the SPARC family and provides a new framework to explain the
288 Hevin is expressed in TM but, in contrast to SPARC, does not appear to be regulated by TGF-beta2.
295 e upregulated genes were SNAI2, FGFBP1, VIM, SPARC (osteonectin), and SERPINE1, while the downregulat
299 6-ring parent PAHs, and correlated well with SPARC octanol/water coefficients (K(OW)) (correlation co
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。